Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03365882	TitleS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	Fase Fase 2	Date Added 2017-12-07	Ubicación Alaska, United States Arizona, United States Arkansas, United States California, United States Colorado, United States Connecticut, United States Florida, United States Georgia, United States Hawaii, United States Idaho, United States Illinois, United States Indiana, United States Iowa, United States Kansas, United States Kentucky, United States Louisiana, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States Mississippi, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States North Carolina, United States North Dakota, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Rhode Island, United States South Carolina, United States Tennessee, United States Texas, United States Utah, United States Vermont, United States Washington, United States West Virginia, United States Wisconsin, United States Wyoming, United States Puerto Rico	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, HER-2 testing, Irinotecan Hydrochloride, Pertuzumab, Trastuzumab, Camptosar, Erbitux, Herceptin, Perjeta	Etiquetas MSS/ MMRp
NCT ID NCT03657641	TitleRegorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2018-09-05	Ubicación California, United States Florida, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Regorafenib, Keytruda, Stivarga	Etiquetas MSS/ MMRp
NCT ID NCT03296137	TitleAdoptive Cell Therapy Across Cancer Diagnoses	Fase Fase 1/Fase 2	Date Added 2017-09-28	Ubicación Dinamarca	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Autologous tumor-infiltrating lymphocytes, Cyclophosphamide, Fludara, Ipilimumab, Nivolumab, proleukin, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT03599765	TitleTerapia sistémica con o sin terapia local consolidada en el tratamiento de pacientes con tumor sólido oligometastásico	Fase Fase 2	Date Added 2018-07-26	Ubicación Arizona, United States Arkansas, United States Hawaii, United States Michigan, United States New Jersey, United States Ohio, United States Texas, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03568058	TitlePersonalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers	Fase Fase 1	Date Added 2018-06-26	Ubicación California, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Pembrolizumab, personalized vaccine, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT04003792	TitleTratamiento con infusión arterial hepática de oxaliplatino en combinación con quimioterapia sistémica FOLFIRI y bevacuzimab en pacientes con metástasis colorrectales hepáticas (CRLM) sólo hepáticas: Conversión a resección completa en pacientes con CRLM sólo hepáticas inicialmente inoperables.	Fase Fase 2	Date Added 2019-07-01	Ubicación Israel	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab, FOLFIRI Protocol, oxaliplatin	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02988960	TitleA Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors	Fase Fase 1	Date Added 2016-12-12	Ubicación California, United States Illinois, United States Massachusetts, United States North Carolina, United States Tennessee, United States Texas, United States Virginia, United States Australia Canadá Francia Japón Corea, República de España	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas ABBV-181, ABBV-927, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT04426669	TitleEstudio de cánceres gastrointestinales metastásicos tratados con linfocitos infiltrantes tumorales en los que se inhibe el gen que codifica el punto de control inmunitario intracelular CISH mediante ingeniería genética CRISPR.	Fase Phase 1, Phase 2	Date Added 2020-06-11	Ubicación Minnesota, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Aldesleukin, Cyclophosphamide, Fludarabine, Tumor Infiltrating Lymphocytes (TIL)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04062721	TitleLocal Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases	Fase Fase 1	Date Added 2019-08-20	Ubicación Francia	Prior IO Allowed Sí	CRC-directed Sí	Status Aún no se ha contratado	Drogas Chemotherapy, In situ immunotherapy	Etiquetas MSS/ MMRp
NCT ID NCT04895709	TitleEstudio de BMS-986340 como monoterapia y en combinación con nivolumab en participantes con tumores sólidos avanzados.	Fase Phase 1, Phase 2	Date Added 2021-05-20	Ubicación California, United States Iowa, United States New Jersey, United States New York, United States Oregon, United States Tennessee, United States Texas, United States Australia Canadá Alemania Israel Italia Japón España	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas BMS-936558-01, BMS-986340	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 51 to 60 of 299 entries